News | May 08, 2023
Galmed Pharmaceuticals forms partnership with OnKai
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
The partnership will commercialize four nasal sprays with a combined Global IQVIA market size in excess of $400m
Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01 January 2026.
Everest and SPH Kyuan will work closely to promote import and channel distribution of XERAVA in China
Affordability is key to providing accessible healthcare for Bharat.
The combination will support clients in getting their end-to-end discovery and development programs delivered.
The milestone of operating continuously a very complex system for over two years has demonstrated the effectiveness of integrated laboratory automation solutions
New York State’s largest health system adopts Philips patient monitoring platform to drive integration and innovation for a better patient and staff experience and improved outcomes
Abbas will closely partner with CBC's business teams to identify, assess, and pursue investment opportunities and strategic acquisitions
Patients will no longer need to travel abroad for treatment of acute cardiac diseases
Subscribe To Our Newsletter & Stay Updated
